Absorbed Dose for Tumor Lesions in Gy/GBq
| Cycles investigated | All metastases | Bone metastases | Lymph node metastases | Liver metastases | Lung metastasis |
| Overall (n) | 93 | 74 | 8 | 8 | 3 |
| Mean ± SD | 3.2 ± 2.6 | 3.4 ± 2.7 | 3.2 ± 2.2 | 1.2 ± 0.67 | 1.75 ± 0.92 |
| Range | 0.22–12.03 | 0.22–12.03 | 1.63–8.46 | 0.47–2.59 | 0.94–2.68 |
| First cycle (n) | 41 | 33 | 5 | 2 | 1 |
| Mean ± SD | 3.5 ± 2.9 | 3.8 ± 3.1 | 2.6 ± 0.89 | 1.7 | 2.7 |
| Range | 0.22–12.03 | 0.22–12.03 | 1.63–3.76 | 0.85–2.59 | |
| Second cycle (n) | 26 | 21 | 2 | 2 | 1 |
| Mean ± SD | 3.3 ± 2.5 | 3.4 ± 2.4 | 5.2 | 0.94 | 1.3 |
| Range | 0.70–8.46 | 1.03–9.59 | 1.98–8.46 | 0.70–1.17 | |
| Third cycle (n) | 14 | 10 | 1 | 2 | 1 |
| Mean ± SD | 2.7 ± 2.3 | 3.2 ± 2.5 | 2.6 | 0.95 | 0.94 |
| Range | 0.94–7.99 | 1.11–7.99 | 18.87 | 0.47–1.42 | |
| Fourth cycle (n) | 12 | 10 | 2 | ||
| Mean ± SD | 2.4 ± 2.2 | 2.7 ± 2.3 | 1.13 | ||
| Range | 0.74–7.60 | 1.04–7.60 | 0.74–1.51 |